etectRx's ingestible adherence tracker system cleared by FDA

etectRx's ingestible adherence tracker system cleared by FDA

Publication Title
Publication/Creation Date
December 9 2019
Dave Muoio (creator)
EtectRx (contributor)
Brigham And Women's Hospital (contributor)
Proteus Digital Health (contributor)
Food And Drug Administration (FDA) (contributor)
Persuasive Intent
"Gainesville, Florida-based etectRx has received FDA 510(k) clearance for its ID-Cap System, a prescription ingestible system that sends adherence event logs to an external medical device.

Similar to the system pioneered by etectRx’s high-profile competitor, Proteus Digital Health, the ID-Cap’s core is a standard capsule containing a sensor that transmits a message once it comes into contact with stomach fluid.

However, the ID-Cap System’s receiving device does not need to be adhered to the user’s skin — as is the case for Proteus’ system — but can instead be worn on a lanyard. This receiver then forwards the adherence event data to secure provider web portal, by way of an intermediary patient smartphone app."

HCI Platform
Relation to Body
Related Body Part
Digestive Tract, Hand, Neck

Date archived
November 5 2020
Last edited
September 30 2021
How to cite this entry
Dave Muoio. (December 9 2019). "etectRx's ingestible adherence tracker system cleared by FDA". MobiHealthNews. MobiHealthNews. Fabric of Digital Life.